Susquehanna International Group
DMK

Susquehanna International Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Susquehanna International Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,600
Closed -$27K – 13810
2023
Q4 		$27K Hold
38,600
– – ﹤0.01% 11903
2023
Q3 		$26.6K Hold
38,600
– – ﹤0.01% 11525
2023
Q2 		$92.3K Buy
38,600
+38,034
+6,720% +$162K ﹤0.01% 11006
2023
Q1 		$4.75K Sell
566
-3,511
-86% -$46.6K ﹤0.01% 12310
2022
Q4 		$48.5K Sell
4,077
-92
-2% -$1.05K ﹤0.01% 11415
2022
Q3 		$58K Sell
4,169
-728
-15% -$18.8K ﹤0.01% 12108
2022
Q2 		$171K Sell
4,897
-49
-1% -$1.53K ﹤0.01% 10868
2022
Q1 		$197K Sell
4,946
-117
-2% -$5.02K ﹤0.01% 11259
2021
Q4 		$216K Sell
5,063
-2,653
-34% -$165K ﹤0.01% 11285
2021
Q3 		$524K Buy
7,716
+4,122
+115% +$302K ﹤0.01% 9271
2021
Q2 		$277K Sell
3,594
-2,973
-45% -$181K ﹤0.01% 10954
2021
Q1 		$432K Buy
+6,567
New +$511K ﹤0.01% 9812
2020
Q4 		– Sell
-530
Closed -$29K – 11895
2020
Q3 		$29K Buy
+530
New +$31.4K ﹤0.01% 10339
2019
Q3 		– Sell
-393
Closed -$36K – 11001
2019
Q2 		$36K Sell
393
-374
-49% -$45.5K ﹤0.01% 9907
2019
Q1 		$113K Buy
+767
New +$148K ﹤0.01% 8198
2018
Q3 		– Sell
-871
Closed -$195K – 10468
2018
Q2 		$195K Sell
871
-1,359
-61% -$364K ﹤0.01% 8632
2018
Q1 		$546K Buy
2,230
+1,087
+95% +$285K ﹤0.01% 6450
2017
Q4 		$352K Buy
1,143
+954
+505% +$314K ﹤0.01% 7312
2017
Q3 		$69K Sell
189
-2,888
-94% -$1.02M ﹤0.01% 8464
2017
Q2 		$1.12M Buy
3,077
+2,154
+233% +$645K ﹤0.01% 5022
2017
Q1 		$275K Buy
+923
New +$233K ﹤0.01% 7480
2016
Q4 		– Sell
-1,030
Closed -$247K – 10313
2016
Q3 		$247K Buy
1,030
+657
+176% +$137K ﹤0.01% 7243
2016
Q2 		$73K Buy
+373
New +$172K ﹤0.01% 8151
2014
Q3 		– Sell
-154
Closed -$52K – 10054
2014
Q2 		$52K Buy
+154
New +$60.5K ﹤0.01% 9582

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $113M AUM 15.01% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Susquehanna International Group's DMK Position: Q1 2024 in Review

Susquehanna International Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 20,237 shares — an estimated $14.2K sold.

Susquehanna International Group first reported a position in DMK in Q2 2014 and held it in 36 quarters. The position peaked at $2.16M in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Susquehanna International Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 20,237 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $14.2K.
  • Susquehanna International Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 36 quarters.
  • Susquehanna International Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.16M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.